The PTBP3 protein mediates TGF-β-induced epithelial-to-mesenchymal transition (Dong et al., 2022) and can serve as an immunomodulatory biomarker of cancer (Chen et al., 2022). This evidence concerns the gene TGFB1 and cancer.